D'Haese Siska, Parmentier Heleen, Keppler Hannah, Van Vooren Sandrien, Van Driessche Veroniek, Bauters Wouter, Van Roost Dirk, Dhooge Ingeborg
a Department of Oto-rhino-laryngology, Ghent University Hospital , Ghent , Belgium.
b Department of Rehabilitation Sciences, Ghent University , Ghent , Belgium.
Acta Otolaryngol. 2019 Sep;139(9):753-758. doi: 10.1080/00016489.2019.1635268. Epub 2019 Jul 8.
Prediction of vestibular schwannoma (VS) growth would allow for a more differentiated follow-up protocol. The natural course of a VS and predictive factors of growth are investigated. Sixty-two sporadic VS cases diagnosed between 2003 and 2015 were included in this retrospective cohort study. After initial surveillance, active therapy was initiated in 31/62 patients. Regular magnetic resonance images (MRIs) were performed. Two mm/year linear difference was the cut-off value for significant growth. The STROBE guidelines have been implemented. Growth of the tumor was detected in 56% of patients and mainly observed in the first three years of follow-up. Tumor size remained stable in 34% and decreased in 10% of patients. No baseline information, symptom, or sign was found to be predictive for growth. In 56% of the initially conservatively managed VSs growth was observed and active treatment was initiated. Eighty-seven percent of the growing VSs were identified during the first three years of follow-up. The initially larger VSs seemed to grow faster and needed active treatment earlier during follow-up. No predicting factors for growth identified from the literature could be confirmed in the present study. Serial MRI remains the appropriate method to detect tumor growth.
预测前庭神经鞘瘤(VS)的生长情况有助于制定更具针对性的随访方案。本研究对VS的自然病程及生长预测因素进行了调查。这项回顾性队列研究纳入了2003年至2015年间诊断的62例散发性VS病例。在初始监测后,62例患者中有31例开始了积极治疗。定期进行磁共振成像(MRI)检查。以每年2毫米的线性差异作为显著生长的临界值。本研究遵循了STROBE指南。56%的患者检测到肿瘤生长,主要发生在随访的前三年。34%的患者肿瘤大小保持稳定,10%的患者肿瘤大小减小。未发现任何基线信息、症状或体征可预测肿瘤生长。在最初采用保守治疗的VS病例中,56%观察到肿瘤生长并开始了积极治疗。87%的生长性VS是在随访的前三年中发现的。最初较大的VS似乎生长更快,在随访期间需要更早开始积极治疗。本研究未能证实文献中报道的任何生长预测因素。连续MRI仍然是检测肿瘤生长的合适方法。